These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28935867)

  • 1. S100A4 contributes to colitis development by increasing the adherence of Citrobacter rodentium in intestinal epithelial cells.
    Zhang J; Jiao Y; Hou S; Tian T; Yuan Q; Hao H; Wu Z; Bao X
    Sci Rep; 2017 Sep; 7(1):12099. PubMed ID: 28935867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary vitamin D3 deficiency alters intestinal mucosal defense and increases susceptibility to Citrobacter rodentium-induced colitis.
    Ryz NR; Lochner A; Bhullar K; Ma C; Huang T; Bhinder G; Bosman E; Wu X; Innis SM; Jacobson K; Vallance BA
    Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(9):G730-42. PubMed ID: 26336925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin mediates Citrobacter rodentium-induced colonic epithelial cell hyperplasia and attaching-effacing lesions.
    Wine E; Shen-Tu G; Gareau MG; Goldberg HA; Licht C; Ngan BY; Sorensen ES; Greenaway J; Sodek J; Zohar R; Sherman PM
    Am J Pathol; 2010 Sep; 177(3):1320-32. PubMed ID: 20651246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors.
    Wu X; Vallance BA; Boyer L; Bergstrom KS; Walker J; Madsen K; O'Kusky JR; Buchan AM; Jacobson K
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G295-306. PubMed ID: 18032474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis.
    Conlin VS; Wu X; Nguyen C; Dai C; Vallance BA; Buchan AM; Boyer L; Jacobson K
    Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G735-50. PubMed ID: 19661153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galactooligosaccharide supplementation provides protection against Citrobacter rodentium-induced colitis without limiting pathogen burden.
    Kittana H; Quintero-Villegas MI; Bindels LB; Gomes-Neto JC; Schmaltz RJ; Segura Munoz RR; Cody LA; Moxley RA; Hostetter J; Hutkins RW; Ramer-Tait AE
    Microbiology (Reading); 2018 Feb; 164(2):154-162. PubMed ID: 29256851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hypoxic exposure on immune responses of intestinal mucosa to Citrobacter colitis in mice.
    Ji Q; Zhang Y; Zhou Y; Gamah M; Yuan Z; Liu J; Cao C; Gao X; Zhang H; Ren Y; Zhang W
    Biomed Pharmacother; 2020 Sep; 129():110477. PubMed ID: 32768962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa.
    Bergstrom KS; Kissoon-Singh V; Gibson DL; Ma C; Montero M; Sham HP; Ryz N; Huang T; Velcich A; Finlay BB; Chadee K; Vallance BA
    PLoS Pathog; 2010 May; 6(5):e1000902. PubMed ID: 20485566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citrobacter rodentium infection causes iNOS-independent intestinal epithelial dysfunction in mice.
    Skinn AC; Vergnolle N; Zamuner SR; Wallace JL; Cellars L; MacNaughton WK; Sherman PM
    Can J Physiol Pharmacol; 2006 Dec; 84(12):1301-12. PubMed ID: 17487239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formyl peptide receptor 2 orchestrates mucosal protection against
    Sharba S; Venkatakrishnan V; Padra M; Winther M; Gabl M; Sundqvist M; Wang J; Forsman H; Linden SK
    Virulence; 2019 Dec; 10(1):610-624. PubMed ID: 31234710
    [No Abstract]   [Full Text] [Related]  

  • 11. High-Throughput Screen Identifies Host and Microbiota Regulators of Intestinal Barrier Function.
    Grosheva I; Zheng D; Levy M; Polansky O; Lichtenstein A; Golani O; Dori-Bachash M; Moresi C; Shapiro H; Del Mare-Roumani S; Valdes-Mas R; He Y; Karbi H; Chen M; Harmelin A; Straussman R; Yissachar N; Elinav E; Geiger B
    Gastroenterology; 2020 Nov; 159(5):1807-1823. PubMed ID: 32653496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice Deficient in Epithelial or Myeloid Cell Iκκβ Have Distinct Colonic Microbiomes and Increased Resistance to
    Mackos AR; Allen JM; Kim E; Ladaika CA; Gharaibeh RZ; Moore C; Parry NMA; Boyaka PN; Bailey MT
    Front Immunol; 2019; 10():2062. PubMed ID: 31552024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonic levels of vasoactive intestinal peptide decrease during infection and exogenous VIP protects epithelial mitochondria against the negative effects of IFNγ and TNFα induced during Citrobacter rodentium infection.
    Maiti AK; Sharba S; Navabi N; Lindén SK
    PLoS One; 2018; 13(9):e0204567. PubMed ID: 30252907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Krüppel-like factor 5 mediates transmissible murine colonic hyperplasia caused by Citrobacter rodentium infection.
    McConnell BB; Klapproth JM; Sasaki M; Nandan MO; Yang VW
    Gastroenterology; 2008 Apr; 134(4):1007-16. PubMed ID: 18395082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial talin-1 protects mice from
    Latour YL; Allaman MM; Barry DP; Smith TM; Williams KJ; McNamara KM; Jacobse J; Goettel JA; Delgado AG; Piazuelo MB; Zhao S; Gobert AP; Wilson KT
    Gut Microbes; 2023; 15(1):2192623. PubMed ID: 36951501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citrobacter rodentium-induced colitis: A robust model to study mucosal immune responses in the gut.
    Koroleva EP; Halperin S; Gubernatorova EO; Macho-Fernandez E; Spencer CM; Tumanov AV
    J Immunol Methods; 2015 Jun; 421():61-72. PubMed ID: 25702536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal Epithelial Cells and the Microbiome Undergo Swift Reprogramming at the Inception of Colonic Citrobacter rodentium Infection.
    Hopkins EGD; Roumeliotis TI; Mullineaux-Sanders C; Choudhary JS; Frankel G
    mBio; 2019 Apr; 10(2):. PubMed ID: 30940698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flagellin-dependent and -independent inflammatory responses following infection by enteropathogenic Escherichia coli and Citrobacter rodentium.
    Khan MA; Bouzari S; Ma C; Rosenberger CM; Bergstrom KS; Gibson DL; Steiner TS; Vallance BA
    Infect Immun; 2008 Apr; 76(4):1410-22. PubMed ID: 18227166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DOCK2 confers immunity and intestinal colonization resistance to Citrobacter rodentium infection.
    Liu Z; Man SM; Zhu Q; Vogel P; Frase S; Fukui Y; Kanneganti TD
    Sci Rep; 2016 Jun; 6():27814. PubMed ID: 27291827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct Immunomodulatory Effects of Spermine Oxidase in Colitis Induced by Epithelial Injury or Infection.
    Gobert AP; Al-Greene NT; Singh K; Coburn LA; Sierra JC; Verriere TG; Luis PB; Schneider C; Asim M; Allaman MM; Barry DP; Cleveland JL; Destefano Shields CE; Casero RA; Washington MK; Piazuelo MB; Wilson KT
    Front Immunol; 2018; 9():1242. PubMed ID: 29922289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.